Significance of the Differential Peptidome in Multidrug-Resistant Tuberculosis

Abstract EN

Most multidrug-resistant tuberculosis (MDR-TB) patients fail to receive a timely diagnosis and treatment.

Therefore, we explored the differentially expressed peptides in MDR-TB compared with drug-susceptible tuberculosis (DS-TB) patients using LC-MS/MS and Ingenuity Pathway Analysis (IPA) to analyse the potential significance of these differentially expressed peptides.

A total of 301 peptides were differentially expressed between MDR-TB and DS-TB groups.

Of these, 24 and 16 peptides exhibited presented high (fold change ≥ 2.0, P < 0.05) and low (fold change ≤ −2.0, P < 0.05) levels in MDR-TB.

Significant canonical pathways included the prothrombin activation system, coagulation system, and complement system.

In the network of differentially expressed precursor proteins, lipopolysaccharide (LPS) regulates many precursor proteins, including four proteins correlated with organism survival.

These four important differentially expressed proteins are prothrombin (F2), complement receptor type 2 (CR2), collagen alpha-2(V) chain (COL5A2), and inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4).

After addition of CR2 peptide, IL-6 mRNA expression in THP-1 cells decreased significantly in dose- and time-dependent manners.

Cumulatively, our study proposes potential biomarkers for MDR-TB diagnosis and enables a better understanding of the pathogenesis of MDR-TB.

The functions of differentially expressed peptides, especially CR2, in MDR-TB require further investigation.